Green SJ - Search Results

1

Phase II study of maytansine in advanced breast cancer.

Edmonson JH, Rubin J, Kvols LK, O'Connell MJ, Frytak S, Green SJ. Edmonson JH, et al. Among authors: green sj. Cancer Treat Rep. 1981 May-Jun;65(5-6):536-7. Cancer Treat Rep. 1981. PMID: 7237478 No abstract available.

2

Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer.

Ingle JN, Ahmann DL, Gerstner JG, Green SJ, O'Connell MJ, Kvols LK. Ingle JN, et al. Among authors: green sj. Cancer Treat Rep. 1984 May;68(5):803-4. Cancer Treat Rep. 1984. PMID: 6722834 No abstract available.

3

Phase II study of chlorozotocin in advanced breast cancer.

Edmonson JH, Green SJ, Ingle JN, Ahmann DL, Disel HF, Creagan ET. Edmonson JH, et al. Among authors: green sj. Cancer Treat Rep. 1981 May-Jun;65(5-6):537-8. Cancer Treat Rep. 1981. PMID: 6453648 No abstract available.

4

Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.

Ingle JN, Ahmann DL, Green SJ, Edmonson JH, Bisel HF, Kvols LK, Nichols WC, Creagan ET, Hahn RG, Rubin J, Frytak S. Ingle JN, et al. Among authors: green sj. N Engl J Med. 1981 Jan 1;304(1):16-21. doi: 10.1056/NEJM198101013040104. N Engl J Med. 1981. PMID: 7001242 Clinical Trial.

5

Evaluation of mitolactol in women with advanced breast cancer and prior chemotherapy exposure.

Ingle JN, Brunk SF, Krook JE, Everson LK, Green SJ, Kvols LK, Etzell PS. Ingle JN, et al. Among authors: green sj. Cancer Treat Rep. 1983 Oct;67(10):955-6. Cancer Treat Rep. 1983. PMID: 6627238 No abstract available.

6

Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanoma.

Creagan ET, Ahmann DL, Green SJ, Long HJ, Rubin J, Schutt AJ, Dziewanowski ZE. Creagan ET, et al. Among authors: green sj. Cancer. 1984 Dec 15;54(12):2844-9. doi: 10.1002/1097-0142(19841215)54:12<2844::aid-cncr2820541205>3.0.co;2-q. Cancer. 1984. PMID: 6498762

7

Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.

Ingle JN, Green SJ, Ahmann DL, Edmonson JH, Nichols WC, Frytak S, Rubin J. Ingle JN, et al. Among authors: green sj. Cancer Res. 1982 Aug;42(8 Suppl):3461s-3467s. Cancer Res. 1982. PMID: 7044529 Clinical Trial.

8

Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer.

Ingle JN, Ahmann DL, Green SJ, Edmonson JH, Creagan ET, Hahn RG, Rubin J. Ingle JN, et al. Among authors: green sj. Am J Clin Oncol. 1982 Apr;5(2):155-60. doi: 10.1097/00000421-198204000-00062. Am J Clin Oncol. 1982. PMID: 7046412 Clinical Trial.

9

Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas.

Edmonson JH, Long HJ, Richardson RL, Creagan ET, Green SJ. Edmonson JH, et al. Among authors: green sj. Cancer Chemother Pharmacol. 1985;15(2):181-2. doi: 10.1007/BF00257535. Cancer Chemother Pharmacol. 1985. PMID: 2990751

10

A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer.

Creagan ET, Green SJ, Ahmann DL, Ingle JN, Edmonson JH, Marschke RF Jr. Creagan ET, et al. Among authors: green sj. J Clin Oncol. 1984 Nov;2(11):1260-5. doi: 10.1200/JCO.1984.2.11.1260. J Clin Oncol. 1984. PMID: 6387059 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

410 results

Search Page

Filters